Clearside Biomedical Eulerpool News

Clearside Biomedical Eulerpool News

Clearside Biomedical Notizie Azioni

Clearside Biomedical è seguito da molti giornalisti e investitori in tutto il mondo. Qui raccogliamo le più recenti notizie Clearside Biomedical.

• 18 settembre ·

  Thefly.com
  JMP Securities healthcare analysts hold an analyst/industry conference call
• 13 settembre ·

  Thefly.com
  JMP Securities healthcare analysts hold an analyst/industry conference call
• 3 settembre ·

  TipRanks
  Buy Rating for Clearside Biomedical’s CLS-AX Based on Superior Efficacy and Market Adoption Potential
• 28 agosto ·

  Thefly.com
  Clearside Biomedical management to meet with Oppenheimer
• 27 agosto ·

  Yahoo
  Clearside Biomedical Announces Completion of Final Participant Visit in ODYSSEY Phase 2b Trial of CLS-AX in Wet AMD
• 27 agosto ·

  TipRanks
  Clearside Biomedical’s CLS-AX Shows Promise in Phase 2b Trials, Yi Chen Maintains Buy Rating with $5 Price Target
• 27 agosto ·

  TipRanks
  Clearside Biomedical: A Strong Buy on Promising ODYSSEY Trial Outcomes and Market Re-Rating Potential
• 27 agosto ·

  TipRanks
  Optimistic Buy Rating for Clearside Biomedical Amid Promising ODYSSEY Trial Results and Strong Financial Position
• 27 agosto ·

  Thefly.com
  Clearside completes final participant visit in CLS-AX trial for wet AMD
• 27 agosto ·

  Thefly.com
  Clearside Biomedical management to meet with Oppenheimer